Year in review 2012: Acute lung injury, interstitial lung diseases, sleep and physiology

Respirology

Volumn 18, Issue 3, 2013, Pages 555-564

  Eves, Neil D ^a   Song, Yuanlin ^b,c   Piper, Amanda ^d,e   Maher, Toby M ^f,g,h  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b FUDAN UNIVERSITY   (China)

^c Shanghai Public Health Clinical Centre   (China)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

adult respiratory distress syndrome; idiopathic pulmonary fibrosis; obesity; obstructive sleep apnoea; sarcoidosis

Indexed keywords

ACETYLCYSTEINE; PLACEBO;

ACUTE LUNG INJURY; AIR POLLUTION; CARDIOVASCULAR DISEASE; DISEASE COURSE; DISEASE SEVERITY; EXERCISE; FIBROSING ALVEOLITIS; HEART FAILURE; HUMAN; HYPOXIA; INFECTION; LUNG FUNCTION; LUNG SARCOIDOSIS; MONOTHERAPY; NONINVASIVE VENTILATION; OBESITY; OBESITY HYPOVENTILATION SYNDROME; OUTCOME ASSESSMENT; PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RARE DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; SLEEP DISORDERED BREATHING;

ACUTE LUNG INJURY; HUMANS; LUNG DISEASES, INTERSTITIAL; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SLEEP;

EID: 84875669188     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12053     Document Type: Review

References (94)

1. Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994; 149: 818-824.
3. Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526-2533.
4. Ristovski ZD, Miljevic B, Surawski NC, et al. Respiratory health effects of diesel particulate matter. Respirology 2012; 17: 201-212.
5. Kendall M, Holgate S,. Health impact and toxicological effects of nanomaterials in the lung. Respirology 2012; 17: 743-758.
6. Holloway JW, Savarimuthu Francis S, Fong KM, et al. Genomics and the respiratory effects of air pollution exposure. Respirology 2012; 17: 590-600.
7. Medhora M, Gao F, Jacobs ER, et al. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology 2012; 17: 66-71.
8. Hegab AE, Nickerson DW, Ha VL, et al. Repair and regeneration of tracheal surface epithelium and submucosal glands in a mouse model of hypoxic-ischemic injury. Respirology 2012; 17: 1101-1113.
9. Song Y, Jayaraman S, Yang B, et al. Role of aquaporin water channels in airway fluid transport, humidification, and surface liquid hydration. J. Gen. Physiol. 2001; 117: 573-582.
10. Song Y, Verkman AS,. Aquaporin-5 dependent fluid secretion in airway submucosal glands. J. Biol. Chem. 2001; 276: 41288-41292.
11. Shen Y, Wang X, Wang Y, et al. Lipopolysaccharide decreases aquaporin 5, but not aquaporin 3 or aquaporin 4, expression in human primary bronchial epithelial cells. Respirology 2012; 17: 1144-1149.
12. Maher TM,. Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. Clin. Chest Med. 2012; 33: 69-83.
13. Shaffiq A, Haitchi HM, Pang YY, et al. A disintegrin and metalloprotease (ADAM) 33 protein in patients with pulmonary sarcoidosis. Respirology 2012; 17: 342-349.
14. Wilsher M, Hopkins R, Zeng I, et al. Prevalence of asthma and atopy in sarcoidosis. Respirology 2012; 17: 285-290.
15. Zappala C, Wells A,. Aetiology and clinical phenotype still seem distant in sarcoidosis. Respirology 2012; 17: 199-200.
16. Patel AS, Siegert RJ, Creamer D, et al. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax 2013; 68: 57-65.
17. Young LM, Good N, Milne D, et al. The prevalence and predictors of airway hyperresponsiveness in sarcoidosis. Respirology 2012; 17: 653-659.
18. De Boer S, Wilsher ML,. Validation of the Sarcoidosis Health Questionnaire in a non-US population. Respirology 2012; 17: 519-524.
19. Maher TM,. Pirfenidone in idiopathic pulmonary fibrosis. Drugs Today 2010; 46: 473-482.
20. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2005; 353: 2229-2242.
21. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 (Suppl. 5): v1-58.
22. Homma S, Azuma A, Taniguchi H, et al. Efficacy of inhaled N-Acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis. Respirology 2012; 17: 467-477.
23. Fahim A, Crooks MG, Wilmot R, et al. Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis. Respirology 2012; 17: 1247-1252.
24. Tasaka S, Mizoguchi K, Funatsu Y, et al. Cytokine profile of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema. Respirology 2012; 17: 814-820.
25. Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 588-594.
26. Fujiwara A, Kobayashi H, Masuya M, et al. Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. Respirology 2012; 17: 693-698.
27. Amar RK, Jick SS, Rosenberg D, et al. Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis. Respirology 2012; 17: 861-868.
28. Kawabata Y, Takemura T, Hebisawa A, et al. Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically. Respirology 2012; 17: 1214-1221.
29. Patel AS, Siegert RJ, Brignall K, et al. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax 2012; 67: 804-810.
30. Nagata K, Tomii K, Otsuka K, et al. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease. Respirology 2012; 17: 506-512.
31. Yokoyama T, Tsushima K, Yamamoto H, et al. Potential benefits of early continuous positive pressure ventilation in patients with rapidly progressive interstitial pneumonia. Respirology 2012; 17: 315-321.
32. Maldonado F, Patel RR, Iyer VN, et al. Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study. Respirology 2012; 17: 455-460.
33. Fernandez Perez ER,. Air hunger, unwelcome guests, clogged pipes and idiopathic inflammatory myositis: can we do better? Respirology 2012; 17: 391-392.
34. Isono S,. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology 2012; 17: 32-42.
35. Sutherland K, Lee RWW, Cistulli PA,. Obesity and craniofacial structure as risk factors for obstructive sleep apnoea: impact of ethnicity. Respirology 2012; 17: 213-222.
36. Joosten SA, Hamza K, Sands S, et al. Phenotypes of patients with mild to moderate obstructive sleep apnoea as confirmed by cluster analysis. Respirology 2012; 17: 99-107.
37. Lam JCM, Mak JCW, Ip MSM,. Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology 2012; 17: 223-236.
38. Schachter L,. Respiratory assessment and management in bariatric surgery. Respirology 2012; 17: 1039-1047.
39. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008; 31: 1079-1085.
40. Brillante R, Laks L, Cossa G, et al. An overnight increase in CO2 predicts mortality in sleep disordered breathing. Respirology 2012; 17: 933-939.
41. Antic NA,. Global warming and increased sleep disordered breathing mortality, rising carbon dioxide levels are a serial pest. Respirology 2012; 17: 885-886.
42. Zhou W, Li S, Wan N, et al. Effects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissues. Respirology 2012; 17: 821-829.
43. Andrews G, Ainslie PN, Shepherd K, et al. The effect of partial acclimatization to high altitude on loop gain and central sleep apnoea severity. Respirology 2012; 17: 835-840.
44. Borel J-C, Borel A-L, Monneret D, et al. Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies. Respirology 2012; 17: 601-610.
45. Castro-Anon O, Golpe R, Perez-De-Llano LA, et al. Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome. Respirology 2012; 17: 1269-1274.
46. Koo BB, Wiggins R, Molina C,. REM rebound and CPAP compliance. Sleep Med. 2012; 13: 864-868.
47. Brillante R, Cossa G, Liu PY, et al. Rapid eye movement and slow-wave sleep rebound after one night of continuous positive airway pressure for obstructive sleep apnoea. Respirology 2012; 17: 547-553.
48. Cheng S-L, Chan VL, Chu C-M,. Compliance with home non-invasive ventilation. Respirology 2012; 17: 735-736.
49. Han F,. Sleepiness that cannot be overcome: narcolepsy and cataplexy. Respirology 2012; 17: 1157-1165.
50. McSharry DG, Ryan S, Calverley P, et al. Sleep quality in chronic obstructive pulmonary disease. Respirology 2012; 17: 1119-1124.
51. Georgiopoulou V,. Laboratory versus field walking tests in moderate COPD: value in simplicity? Respirology 2012; 17: 197-198.
52. Jones LW, Watson D, Herndon JE 2nd, et al. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer 2010; 116: 4825-4832.
53. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211-277.
54. Hill K, Dolmage TE, Woon L, et al. Comparing peak and submaximal cardiorespiratory responses during field walking tests with incremental cycle ergometry in COPD. Respirology 2012; 17: 278-284.
55. du Bois RM, Weycker D, Albera C, et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am. J. Respir. Crit. Care Med. 2011; 183: 1231-1237.
56. Eiser N, Willsher D, Dore CJ,. Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients. Respir. Med. 2003; 97: 407-414.
57. Paisani DM, Fiore JF Jr, Lunardi AC, et al. Preoperative 6-min walking distance does not predict pulmonary complications in upper abdominal surgery. Respirology 2012; 17: 1013-1017.
58. Wilsher M, Good N, Hopkins R, et al. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease. Respirology 2012; 17: 647-652.
59. Holland AE, Goh NS,. The six-minute walk test in scleroderma: what should we measure and how should we measure it? Respirology 2012; 17: 588-589.
60. Yu CC, Li AM, Au CT, et al. Follow up of aerobic capacity in children affected by severe acute respiratory syndrome. Respirology 2012; 17: 513-518.
61. Takahashi K, Eves ND, Piper A, et al. Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer. Respirology 2012; 17: 554-562.
62. Liang BM, Lam DC, Feng YL,. Clinical applications of lung function tests: a revisit. Respirology 2012; 17: 611-619.
63. Mehrparvar AH, Rahimian M, Mirmohammadi SJ, et al. Comparison of FEV(3), FEV(6), FEV(1)/FEV(3) and FEV(1)/FEV(6) with usual spirometric indices. Respirology 2012; 17: 541-546.
64. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 2012; 40: 1324-1343.
65. Hall GL, Thompson BR, Stanojevic S, et al. The Global Lung Initiative 2012 reference values reflect contemporary Australasian spirometry. Respirology 2012; 17: 1150-1151.
66. Piatti G, Fasano V, Cantarella G, et al. Body plethysmographic study of specific airway resistance in a sample of healthy adults. Respirology 2012; 17: 976-983.
67. Gochicoa LG, Thome-Ortiz LP, Furuya ME, et al. Reference values for airway resistance in newborns, infants and preschoolers from a Latin American population. Respirology 2012; 17: 667-673.
68. Buyse B, Demedts M, Meekers J, et al. Respiratory dysfunction in multiple sclerosis: a prospective analysis of 60 patients. Eur. Respir. J. 1997; 10: 139-145.
69. Mutluay FK, Gurses HN, Saip S,. Effects of multiple sclerosis on respiratory functions. Clin. Rehabil. 2005; 19: 426-432.
70. Chiara T, Martin AD, Davenport PW, et al. Expiratory muscle strength training in persons with multiple sclerosis having mild to moderate disability: effect on maximal expiratory pressure, pulmonary function, and maximal voluntary cough. Arch. Phys. Med. Rehabil. 2006; 87: 468-473.
71. Carvalho SR, Alvarenga Filho H, Papais-Alvarenga RM, et al. Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability? Respirology 2012; 17: 869-875.
72. Corish CA, Kennedy NP,. Protein-energy undernutrition in hospital in-patients. Br. J. Nutr. 2000; 83: 575-591.
73. Rochester DF, Esau SA,. Malnutrition and the respiratory system. Chest 1984; 85: 411-415.
74. Norman K, Pichard C, Lochs H, et al. Prognostic impact of disease-related malnutrition. Clin. Nutr. 2008; 27: 5-15.
75. Qaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann. Intern. Med. 2006; 144: 575-580.
76. Lunardi AC, Miranda CS, Silva KM, et al. Weakness of expiratory muscles and pulmonary complications in malnourished patients undergoing upper abdominal surgery. Respirology 2012; 17: 108-113.
77. Corte TJ, Wort SJ, MacDonald PS, et al. Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia. Respirology 2012; 17: 674-680.
78. Seccombe LM, Rogers PG, Jenkins CR, et al. Maintenance of vital capacity during repetitive breath-hold in a spearfishing competition. Respirology 2012; 17: 350-353.
79. Briet M, Collin C, Laurent S, et al. Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension 2007; 50: 970-976.
80. Ling SH, van Eeden SF,. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int. J. Chron Obstruct. Pulmon Dis. 2009; 4: 233-243.
81. Kelly FJ, Fuller GW, Walton HA, et al. Monitoring air pollution: use of early warning systems for public health. Respirology 2012; 17: 7-19.
82. Sierra-Vargas MP, Teran LM,. Air pollution: impact and prevention. Respirology 2012; 17: 1031-1038.
83. Tam WW, Wong TW, Wong AH, et al. Effect of dust storm events on daily emergency admissions for respiratory diseases. Respirology 2012; 17: 143-148.
84. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557-567.
85. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. (Lond.) 2008; 32: 1431-1437.
86. Lin CK, Lin CC,. Work of breathing and respiratory drive in obesity. Respirology 2012; 17: 402-411.
87. Littleton SW,. Impact of obesity on respiratory function. Respirology 2012; 17: 43-49.
88. Dreher M, Kabitz HJ,. Impact of obesity on exercise performance and pulmonary rehabilitation. Respirology 2012; 17: 899-907.
89. Bahammam AS, Al-Jawder SE,. Managing acute respiratory decompensation in the morbidly obese. Respirology 2012; 17: 759-771.
90. Feng K, Chen L, Han SM, et al. Ratio of waist circumference to chest circumference is inversely associated with lung function in Chinese children and adolescents. Respirology 2012; 17: 1114-1118.
91. Chen Y, Rennie D, Cormier Y, et al. Waist circumference associated with pulmonary function in children. Pediatr. Pulmonol. 2009; 44: 216-221.
92. Sahay S, Krasuski RA, Tonelli AR,. Partial anomalous pulmonary venous connection and pulmonary arterial hypertension. Respirology 2012; 17: 957-963.
93. Sears EH, Aliotta JM, Klinger JR,. Partial anomalous pulmonary venous return presenting with adult-onset pulmonary hypertension. Pulm. Circ. 2012; 2: 250-255.
94. Babb JD, McGlynn TJ, Pierce WS, et al. Isolated partial anomalous venous connection: a congenital defect with late and serious complications. Ann. Thorac. Surg. 1981; 31: 540-541.